Cycloserine labels and packages: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 25: Line 25:
{|
{|
|-
|-
| [[File:Seromycin 1|800px|thumb]]
| [[File:Seromycin 1.jpg|800px|thumb]]
|-
|-
|}
|}

Revision as of 18:30, 26 December 2013

Cycloserine
SEROMYCIN ® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]


PACKAGE LABEL PRINCIPAL DISPLAY PANEL

SEROMYCIN cycloSERINE Capsules, USP 250mg THE CHAO CENTER NDC 13845-1200-3 40 capsules Rx only

Usual Initial Adult Dose: One capsule (250 mg) twice a day at 12 hour intervals. See accompanying literature. Dispense in a tight container.

WARNING: Potent drug. May cause serious reactions in some individuals. Use in patients under close medical supervision. Read accompanying literature before using.

13845-1200-3

LM000250.00

Keep tightly closed. Store at controlled room temperature, 20 degrees to 25 degrees C (68 degrees to 77 degrees F). [see USP]

Maunfacture The Chao center for Industrial Pharmacy and Contract Manufacturing, West Lafayette, IN 47906, USA

Expiration Date Batch No.[1]



References

  1. "SEROMYCIN (CYCLOSERINE) CAPSULE [PURDUE GMP CENTER LLC DBA THE CHAO CENTER]". Text " accessdate " ignored (help)

Adapted from the FDA Package Insert.